Search

everythinglearnresearchcommunity

for

Search:↓

Many LGBTQ individuals in Lahore face skin issues, with androgenic alopecia, dry skin, and scabies being common, highlighting the need for better healthcare access and provider training.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Dermatologists are crucial in providing personalized care for patients with sex development differences.

Cathelicidins could treat skin issues but face challenges like safety and resistance.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

The transfollicular route shows promise for noninvasive, targeted drug delivery but needs more research.

Microneedles can improve skin disease treatment by delivering drugs directly through the skin.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

Understanding sex and gender differences can improve personalized dermatology care.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Laser treatment for skin conditions VEN and ILVEN is effective and liked by patients.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Beard hair transplantation is generally satisfying, requires 250-800 grafts, uses FUE to avoid scars, needs careful planning, has some risks, and hair regrowth starts after 4-6 months.